Position in AXSM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,425,097
New position
Shares Held
30,335
first reported quarter
Ownership
0.058%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#139
of 504 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026AustralianSuper Pty Ltd holds $157,332,349 across 6 Biotechnology names. AXSM ranks #3 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,196,491 | $135,634,219 | |
| 2 | ARGX |
Argenx SE
|
11,380 | $10,558,022 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
This page
|
30,335 | $7,425,097 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,032 | $1,506,085 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,803 | $1,445,847 | |
| 6 | INSM |
INSMED Inc
|
7,157 | $763,079 |
All Filings in AXSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,425,097 | 30,335 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||